Eylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion
Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
Comparing time to recurrence of macular edema after an initial loading dose of at least three
monthly anti VEGF injections (aflibercept or ranibizumab) for macular edema in BRVO.